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by Yoshihiko Yokose,* Kazuhiko Uchida,* Dai Nakae,*
Kazumi Shiraiwa,* Kazuhiko Yamamoto,* and Yoichi
Konishi*t
The carcinogenic activities of sodium chlorite in B6C3F1 mice were examined. Sodium chlorite was
given at concentrations of 0 (control), 0.025% (low dose), or 0.05% (high dose) in the drinking water of
150 female and 150 male mice for 80 weeks, after which time the animals were returned to distilled water
without sodium chlorite. All mice were sacrificed 85 weeks from the beginning of the experiment. The
incidence of tumor-bearing animals was 32% (control), 34% (low dose), and 26% (high dose) in female
mice, and 46% (control), 57% (low dose), and 53% (high dose) in male mice. The types and incidence of
neoplasms that occurred frequently in each group of both sexes were similar to those observed sponta-
neously in B6C3F1 mice. The incidence oflymphomas/leukemias in the high dose group offemales (2%),
however, was lower than that in the control group (15%). Furthermore, the incidence of pulmonary
adenomas in the high dose group of males (12%) was higher than that in the control group (0%o), but
neither dose-related increases in the adenoma incidences nor increased incidences ofthe adenocarcinomas
were observed. These results indicated no clear evidence ofa carcinogenic potential ofsodium chlorite in
B6C3F1 mice.
Introduction
Since 1958, sodium chlorite has been used in Japan
(1) as a bleaching agent for cherry, grape, peach, and
butterbur in the process of preservation in sugar. In
the United States, the primary method of water dis-
infection uses chlorine. However, it has become clear
that chlorine interacts with organics in the water to
form trihalomethanes such as chloroform, bromodichlo-
romethane, dibromochloromethane, andbromoform (2).
Chloroform has been shown to be carcinogenic in mice
and rats (3). Ithas also beenpostulatedthatchlorinated
water supplies may increase the risk of cancer in
humans (4-7). From these observations, chlorine diox-
ide was suggested as an attractive alternative disinfec-
tant. Chlorine dioxide does not form trihalomethanes,
but it forms chlorite and chlorate as by-products in con-
centrations of50% and 30% ofits demand, respectively
(8). While toxicological studies have revealed limited
physiologic effects fromchlorine dioxide, oral acute dos-
esofsodiumchloratehaveresultedinhemolysis, nephri-
tis, methemoglobinemia, and death in man and various
species of test animals (9). Based on these findings, a
number of acute and chronic toxicological studies on
chlorite were performed in laboratory animals (10-13),
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since chlorite is thought to be the most potentiallytoxic
by-product (14,15).
Recently, a potential promoting effect of sodium
chlorite was suspected in two-stage skin carcinogenesis
using female Sencar mice (16). In another study, it had
been shown that sodium chlorite was positive in both
Ames tests and chromosome tests (17). TR values cal-
culated in the chromosome test, which indicates the
frequency of cells with exchange-type aberrations per
unit dose (mg/mL), were high (17), indicating that
sodium chlorite may possess carcinogenic potential in
animals (18). This paper reports the results of a long-
term carcinogenicity testing of sodium chlorite in
B6C3F1 mice.
Materials and Methods
Chemicals
Sodium chlorite wasobtainedfromWakoPure Chem-
ical Industries, Ltd. (Kyoto, Japan) in a single batch
(purity82-87%) and was administered orallyto animals
in drinking water at various concentrations mentioned
below. The drinking water was prepared and supplied
fresh three times a week in light-proofbottles.
Animals and Maintenance
Three hundred B6C3F1 mice (150 females and 150
males) were purchased from Shizuoka Laboratory Cen-YOKOSE ET AL.
ter (Shizuoka, Japan). Mice were given a pellet diet
(CRF-1; Charles River Japan, Inc., Kanagawa, Japan)
ad libitum. The mice were 6 weeks old at the beginning
ofthe experiment and were housed five to six in plastic
cages, with wood chips as bedding. The room temper-
ature was kept at 23 + 2°C and the humidity at 55 ±
10%, with a 12-hr light/dark cycle.
Experimental Procedure
Groups of50 mice ofeach sex were given the sodium
chlorite solution ataconcentrationof0 (control), 0.025%
(low dose), or 0.05% (high dose) for 80 weeks followed
by distilled water alone for another 5 weeks. The high
dose was chosen after a preliminary 13-week subacute
toxicity study. In the subacute toxicity study, nine
doses ofsodium chlorite, 0, 0.00625, 0.0125, 0.025, 0.05,
0.1, 0.25, 0.5, and 1% in drinking water, were used.
Mice given higher doses than 0.25% died ofdehydration
due to a strong smell ofthe sodium chlorite-containing
water. The dose of 0.1% exerted 7% and 6% growth
retardation in female and male mice, respectively. The
dose of0.05% exerted, respectively, 2% and 4% growth
retardation in females and males. Because ofa narrow
tolerance range between the doses of 0.1% and 0.25%,
we selected the dose of 0.05% as the highest dose for
long-term carcinogenicity studies of sodium chlorite.
According to the guideline for carcinogenicity studies
from the Ministry of Health and Welfare ofJapan, the
test compound was withdrawn for the final 5 weeks.
The withdrawal may further progress the induced tu-
mor growth or regress reversible proliferative lesions,
which makes ahistological evaluation oftest compounds
easier. The animals were observed daily for abnormal-
ities. Individualbodyweights wererecorded weekly for
the first 13 weeks and every other week thereafter.
Waterconsumptionwasmeasured overthe 1-dayperiod
before each weighing.
After 85 weeks, surviving animals were deprived of
food, but not water, overnight and then killed under
ether anesthesia by exsanguination from the aorta. Pe-
ripheral blood was taken from each mouse for the mi-
croscopical examination by Giemsa stain.
Gross findings were recorded and the following or-
gans of each mouse were weighed: brain, heart, lung,
liver, pancreas, spleen, kidney, adrenals, and testes or
ovaries. Samples ofthese organs and ofsalivary gland,
trachea, thymus, lymph nodes, stomach, small intes-
tine, large intestine, urinary bladder, pituitary, thy-
roid, prostate, seminal vesicle, uterus, vagina, mam-
mary gland, skeletal muscle, eye, Harderian glands,
spinal cord, bone (sternal bone, ribs, vertebral bone),
and other tissues with abnormal appearance were fixed
in 10% neutralized formalin. Preserved tissues to be
examined microscopically were embedded in paraffin
wax, sectioned, and stained with hematoxylin and eosin
(HE). Histopathological examinations were also per-
formed on mice found dead and those in moribund con-
dition when killed.
Statistical Analyses
Data on cumulative mortality and tumor incidence
were analyzed for statistical significance by the chi-
square test.
Results
Body Weights
Growth curves offemale and male mice are shown in
Figures 1 and 2. Female mice ofeachgroupgainedbody
weight up to 60 weeks; however, thereafter, the mice
given a high dose ofsodium chlorite showed a decrease
in body weight gain compared to other groups. Male
mice of each group showed a decrease in body weight
after 65 weeks. Final body weights offemale and male
mice showed no significant differences among each
group.
Water Consumption
Throughout the study, the rate ofwater consumption
by female mice in any group treated with sodium chlor-
ite showed no consistent deviation from the control. On
the otherhand, waterconsumptionbymalemicetreated
with a high dose of sodium chlorite was slightly lower
thanthe othergroups. Fortreated groups, totalintakes
of sodium chlorite for 80 weeks, calculated from mean
water consumption collected on46different days during
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FIGURE 1. Growth curves offemale B6C3F1 mice given sodium chlor-
ite in drinking water at concentrations of0 (control) (0-o), 0.025
(-*), or 0.05% (A-A).
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50 after 34 weeks. The percentages of mice surviving at
week 85 were as follows: females-control, 47/50 (94%);
lowdose, 50/50(100%); highdose, 50/50(100%); males
control, 35/50 (70%); low dose, 47/50 (94%); high dose,
43/50 (86%).
40-
Organ Weights
Organweightsandpercentorgantobodyweightratio
for each group of both sexes are shown in Table 1. No
significant increases with dose dependency were seen
Q30 -z in any organ weight and percent organ to body weight
ratio of both females and males treated with sodium
E: tchlorite compared to control groups.
24
Histopathological Findings
0 10 20 30 40 50 60 70 80 90 Tumor distribution and incidence in each group of
both sexes are shown in Table 2. Mice surviving 85 Observation period (Weeks) weeks were included in the effective number. The in-
FIGURE 2. Growth curves ofmale B6C3F1 micegiven sodiumchlorite cidence of tumor-bearing animals were as follows: fe-
in drinking water at concentrations of 0 (control) (o-o), 0.025 males-control, 15/47(32%); lowdose, 17/50(34%); high
(0-@), or 0.05% (A-A). dose, 13/50 (26%); males-control, 16/35 (46%); low
dose, 27/47 (57%); high dose, 23/43 (53%). Tumors de-
veloped in the liver, lung, hematopoietic system, Har-
the study for a mouse from each group, were 658 and derian gland, spleen, subcutis, pituitary, thyroid, and
1067 mg/mouse in the low dose group, and 1261 and ovary in the control and each treated group. Histolog-
1606 mg/mouse in the high dose group for females and ically, the lesions of the liver were classified as hyper-
males, respectively. plastic nodule, hepatocellular carcinoma, and heman-
gioma. Hyperplastic nodules were sharply demarcated
Survival lesions, which showed proliferation of hepatocytes. They were as large as or largerthan the area ofseveral
Survival curves for the control and treated groups of lobules. The cells, having enlarged and hyperchromatic
female and male mice are shown in Figures 3 and 4, nuclei and prominent nucleoli, varied in size and were
respectively. There was no dose-related trend in mor- arranged as single or double layers in plates. Hepato-
tality over the experimental period in the control and cellular carcinomas had a trabecular structure with cel-
other treated groups for females and males. Male mice lular or nuclear atypism. Some of these lesions metas-
in the control group were lost mainly due to fighting tasized to the lung; one case occurred in both the low
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FIGURE 3. Survival rates of female B6C3F1 mice given sodium chlorite in drinking water at concentrations of 0 (control) (- ), 0.025
(), or 0.05% (---).
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FIGURE 4. Survival rates of male B6C3F1 mice given sodium chlorite in drinking water at concentrations of 0 (control) ( ), 0.025 (-),
or 0.05% (---).
and the high dose group of males. Lesions more fre-
quently encountered in each group of male mice were
hyperplastic nodules and hepatocellular carcinomas;
however, no significant differences were found between
control and treated groups. Hemangiomas were ob-
served sporadically in the low dose group of female
mice.
Histologically, the lesions of the lung were classified
into adenomas and adenocarcinomas. The incidence of
adenomas in the high dose group of males was signifi-
cantly higher than that ofthe control group. No signif-
icant differences were found in the incidence of adeno-
carcinomas between control and treated groups ofboth
sexes.
Malignantlymphomas/leukemias werefrequentinthe
control group of both sexes, but their incidence was
significantly lower in the high dose group of females.
Peripheral blood samples stained byGiemsashowed the
appearance of lymphoblast cells. However, abnormali-
ties ofred blood cells, including acanthocytes, were not
observed. The incidence oftumorsin other organs, e.g.,
Harderian gland, spleen, subcutis, pituitary, thyroid,
and ovary, were not significantly different from those
of controls ofboth sexes in any ofthe three groups.
Nonneoplastic lesions in various organs were infre-
quent, and no significant differences in the incidence
between control and treated groups were found.
Discussion
Accordingto previous reports (19-21), the most com-
mon neoplasms that occurred spontaneously in B6C3F1
male mice during the observation period of 79 to 104
weeks were hyperplastic nodules of the liver (the inci-
dence was 7.9-28.2%), hepatocellular carcinoma (13.7-
19.6%), lymphomas/leukemias (4.3-12.8%), and pul-
monary adenomas (2.2-7.7%) and carcinomas (2.1-
6.5%). In female mice, common tumors were lympho-
mas/leukemias (16-25%), pulmonary adenomas (2.1-
4.4%) and carcinomas (0-2.1%), hyperplastic nodules of
Table 1. Final body weights and organ weights of B6C3F1 mice given sodium chlorite in drinking water.
No. of Body weight, g Organ weight, ga (% ofbody weight)
Dose, mice
% Sex examined Initial Final Lung Liver Pancreas Kidney Spleen Heart Brain
0 F 47 20.0 ± 1.0 48.4 ± 3.7 0.36 ± 0.21 1.54 ± 0.34 0.33 ± 0.07 0.46 ± 0.27 0.17 ± 0.19 0.13 ± 0.03 0.44 ± 0.03
(0.71) (3.18) (0.68) (0.95) (0.35) (0.27) (0.91)
M 35 25.6 ± 1.1 40.3 ± 2.5 0.40 ± 0.10 1.95 ± 0.73 0.43 ± 0.81 0.67 ± 0.10 0.18 ± 0.27 0.21 ± 0.05 0.46 ± 0.05
(0.99) (4.8) (1.07) (1.66) (0.45) (0.52) (1.14)
0.025 F 50 19.9 ±0.3 50.8±2.5 0.44±0.13 1.70±0.42 0.38±0.14 0.48±0.09 0.24±0.54 0.17±0.03 0.46±0.03
(0.87) (3.35) (0.75) (0.94) (0.47) (0.33) (0.91)
M 50 25.5 ± 0.6 40.3 ± 2.0 0.38 ± 0.07 2.06 ± 1.12 0.36 ± 0.10 0.65 ± 0.08 0.13 ± 0.10 0.21 ± 0.03 0.44 ± 0.05
(0.94) (5.11) (0.89) (1.61) (0.32) (0.52) (1.09)
0.05 F 50 19.4 ± 0.4 47.4 ± 3.9 0.38 ± 0.09 1.58 ± 0.49 0.37 ± 0.44 0.45 ± 0.06 0.25 ± 0.41 0.15 ± 0.03 0.44 ± 0.05
(0.80) (3.33) (0.78) (0.95) (0.53) (0.31) (0.93)
M 50 26.0 ± 0.1 42.7 ± 1.2 0.43 ± 0.15 2.33 ± 1.28 0.40 ± 0.12 0.66 ± 0.09 0.16 ± 0.16 0.21 ± 0.03 0.43 ± 0.05
(1.10) (5.47) (0.94) (1.55) (0.37) (0.49) (1.01)
aValues represent average ± SD.
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Table 2. Tumor distribution and incidence in B6C3F1 mice given sodium chlorite in drinking water.
No. of Tumor distribution and incidence, %
Effective tumor Liver Lung Harderian Spleen Subcutis Pituitary Thyroid Ovary
Dose, no. of bearing MLY/
% Sex micea mice, % HN HCC H A AC T H FS MFH A A PA LEU
0 F 47 15(32) 5(11) 0 (0) 0(0) 3 (6) 0(0) 2(4) 0(0) 0(0) 0(0) 2(4) 0(0) 0(0) 7(15)
M 35 16(46) 6(17) 4(11) 0(0) 0 (0) 0(0) 1(3) 1(3) 0(0) 0(0) 0(0) 0(0) 4(11)
0.025 F 50 17(34) 3 (6) 1 (2) 1(2) 1 (2) 1(2) 4(8) 0(0) 0(0) 0(0) 0(0) 1(2) 1(2) 5(10)
M 47 27(57) 14(30) 8(17) 0(0) 2 (4) 1(2) 3(6) 0(0) 2(4) 0(0) 0(0) 0(0) 2(4)
0.05 F 50 13(26) 5(10) 1 (2) 0(0) 2 (4) 0(0) 4(8) 1(2) 0(0) 0(0) 0(0) 0(0) 0(0) 1 (2)b
M 43 23(53) 11(26) 6(14) 0(0) 5(12)b 2(5) 1(2) 0(0) 1(2) 1(2) 0(0) 0(0) 1 (2)
HN, hyperplastic nodule; HCC, hepatocellular carcinoma; H, hemangioma; A, adenoma; AC, adenocarcinoma; MLY/LEU, malignant lym-
phoma/leukemia; T, tumor; FS, fibrosarcoma; MFH, malignant fibrous histiocytoma; PA, papillary adenoma.
aBased on histological examination of mice sacrificed 85 weeks after the beginning of the experiment.
bp <0.05 against 0% group.
the liver (1.1-4.4%) and carcinomas (1.8-4.4%), and pi-
tuitary adenomas (3-8.3%).
In the present study, the neoplasms that occurred
frequently in each group of both sexes were similar to
those mentioned above; however, the incidence of pul-
monary adenoma in the high dose group of males was
higher than the incidence of spontaneous tumors re-
ported, and the incidence of lymphomas/leukemias in
the high dose group offemales was lower. The present
result showing a significantly higher incidence of lung
adenomas in the high dose group ofmales might either
be attributed to a statistical variation resulting from
the too lowadenomaincidence in controlmales, ormake
a strong case for further intensive studies on the car-
cinogenicity ofsodium chlorite. In any case, takinginto
account of the absence of dose-related increases in the
incidences of lung adenomas and the lack of increased
incidences oflungadenocarcinomas, itwould notbepos-
sible from ourpresentresults to conclude acarcinogenic
potential ofsodium chlorite for the lung in mice. In this
context, reportedly, chlorite preferably distributes to
the blood, testis, and lung after the oral administration
in rats (22). Further, a weak promoting activity of so-
dium chlorite has been reported in two-stage skin car-
cinogenesis in Sencar mice (16). Further studies would
be required to conclude the carcinogenicity ofthis sub-
stance.
Moore et al. (23) reported that chlorite produced in-
creases in osmotic fragility, mean corpuscular volume
and glucose-6-phosphate dehydrogenase activity ofred
blood cells, and number of acanthocytes in A/J and
C57L/J mice on exposure to a dose of 100 ppm in drink-
ing water for 30 days. The morphological distortions in
erythrocytes have also been reported in the rat and
chicken (24). In the present study, no alteration was
observed in erythrocyte morphology even in the high
dose groups (500 ppm) ofboth sexes.
Because sodium chlorate caused toxic damage to the
kidneys (9), ithasbeenpostulatedthatchlorite, because
of its more potent oxidant capabilities (14,15), may be
potentially more harmful to the kidney. Recently,
Moore et al. (12,23) and Connor et al. (25) reported the
lack ofthe nephrotoxicity ofsodium chlorite in mice and
rats; sodium chlorite was administered orally in drink-
ing water for 180 days at a concentration up to 100 ppm
in mice and 500 ppm in rats. Our present study was
performed at five times higher dose and three times
longerperiods thanthose inprevious reports (12,22,24).
Nevertheless, no effects were produced in the kidney
by sodium chlorite. Therefore, our present data confirm
previous reports that no significant difference existed
in the mean kidney weights and the percent kidney to
body weight ratio between control and treated groups,
and, moreover, histological examination did not reveal
any detectable toxic damage to the kidneys of each
treated group of both sexes.
Abdel-Rahman et al. (26) reported that administra-
tion ofchlorine dioxide and/or its by-products to rats in
drinking water for 3 months interfered with DNA syn-
thesis athighdosesintheintestinal mucosaandatlower
doses in testes and liver. The significance of these re-
sults is presently obscure; however, it is interesting to
note whether or not the apparent depression of DNA
synthesis in the testes is associated with depressed
spermatogenesis and reproductive toxicity in the male
rat (27). In the present study, no remarkable histolog-
ical changes of the testes and intestine were observed
in any of the treated groups.
In the present study, clear evidence of carcinogenic
activities of sodium chlorite in B6C3F1 mice was not
observed. However, considering that this substance is
widely used as an environmental chemical, further ex-
perimental studies will be necessary to identify and
quantify more clearly the hazards of this substance.
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